Related Experiment Video
Updated: Jul 12, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Treatment modalities in endometrial cancer
Frederic Amant1, Philippe Moerman, Patrick Neven
1Leuven Cancer Institute (LKI), UZ Gasthuisberg, Katholieke Universiteit, Leuven, Belgium.
Current Opinion in Oncology
|September 1, 2007
Summary
New insights into endometrial cancer reveal subtype-specific surgical staging and adjuvant treatments. Tailored approaches, including chemotherapy, improve survival for high-risk patients.
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
Background:
- Endometrial cancer is the most common female genital tract malignancy.
- Understanding tumor spread and treatment nuances is critical for patient outcomes.
Purpose of the Study:
- To review new insights into endometrial cancer management.
- To highlight practice-changing advancements in surgical staging and adjuvant therapies.
Main Methods:
- Review of recent data on endometrial cancer treatment.
- Analysis of surgical staging procedures based on cancer subtype.
- Evaluation of adjuvant treatment modalities, including chemotherapy and hormonal therapy.
Main Results:
- Metastatic patterns differ between Type 1 and Type 2 endometrial cancers, necessitating subtype-specific surgical staging.
- Laparoscopic staging and treatment are safe and effective.
- Adequate staging and adjuvant chemotherapy show improved survival, particularly in early-stage serous endometrial cancer.
- Adjuvant chemotherapy may be more effective than radiotherapy for Type 1 cancers.
- Hormonal treatment can benefit advanced or recurrent disease.
Conclusions:
- Recent findings offer new perspectives on tumor spread in endometrial cancer.
- Surgical staging and adjuvant treatment strategies are evolving based on new evidence.
- Personalized treatment approaches are key to improving outcomes for endometrial cancer patients.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...